BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17822698)

  • 1. Modulation of polyglutamine inclusion formation by the Hsp70 chaperone machine.
    Rujano MA; Kampinga HH; Salomons FA
    Exp Cell Res; 2007 Oct; 313(16):3568-78. PubMed ID: 17822698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of HSP70 expression and recruitment of HSC70 and HSP70 in the nucleus reduce aggregation of a polyalanine expansion mutant of PABPN1 in HeLa cells.
    Wang Q; Mosser DD; Bag J
    Hum Mol Genet; 2005 Dec; 14(23):3673-84. PubMed ID: 16239242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DnaK and DnaJ facilitated the folding process and reduced inclusion body formation of magnesium transporter CorA overexpressed in Escherichia coli.
    Chen Y; Song J; Sui SF; Wang DN
    Protein Expr Purif; 2003 Dec; 32(2):221-31. PubMed ID: 14965767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion body anatomy and functioning of chaperone-mediated in vivo inclusion body disassembly during high-level recombinant protein production in Escherichia coli.
    Rinas U; Hoffmann F; Betiku E; Estapé D; Marten S
    J Biotechnol; 2007 Jan; 127(2):244-57. PubMed ID: 16945443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic changes in the localization of thermally unfolded nuclear proteins associated with chaperone-dependent protection.
    Nollen EA; Salomons FA; Brunsting JF; van der Want JJ; Sibon OC; Kampinga HH
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12038-43. PubMed ID: 11572931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with extracellular HSP70/HSC70 protein can reduce polyglutamine toxicity and aggregation.
    Novoselova TV; Margulis BA; Novoselov SS; Sapozhnikov AM; van der Spuy J; Cheetham ME; Guzhova IV
    J Neurochem; 2005 Aug; 94(3):597-606. PubMed ID: 15992387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mechanism of Hsp70 chaperone-mediated prevention of polyglutamine aggregates in a cellular model of huntington disease.
    Guzhova IV; Lazarev VF; Kaznacheeva AV; Ippolitova MV; Muronetz VI; Kinev AV; Margulis BA
    Hum Mol Genet; 2011 Oct; 20(20):3953-63. PubMed ID: 21775503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer.
    Wacker JL; Zareie MH; Fong H; Sarikaya M; Muchowski PJ
    Nat Struct Mol Biol; 2004 Dec; 11(12):1215-22. PubMed ID: 15543156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A platform to view huntingtin exon 1 aggregation flux in the cell reveals divergent influences from chaperones hsp40 and hsp70.
    Ormsby AR; Ramdzan YM; Mok YF; Jovanoski KD; Hatters DM
    J Biol Chem; 2013 Dec; 288(52):37192-203. PubMed ID: 24196953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative evaluation of chaperone activity and neuroprotection by different preparations of a cell-penetrating Hsp70.
    Nagel F; Dohm CP; Bähr M; Wouters FS; Dietz GP
    J Neurosci Methods; 2008 Jun; 171(2):226-32. PubMed ID: 18455803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock protein 40/DjB1 is required for thermotolerance in early phase.
    Uchiyama Y; Takeda N; Mori M; Terada K
    J Biochem; 2006 Dec; 140(6):805-12. PubMed ID: 17050614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic regulation of molecular chaperone gene expression in polyglutamine disease.
    Huen NY; Chan HY
    Biochem Biophys Res Commun; 2005 Sep; 334(4):1074-84. PubMed ID: 16039613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the chaperone DnaK in protein solubility and conformational quality in inclusion body-forming Escherichia coli cells.
    Martínez-Alonso M; Vera A; Villaverde A
    FEMS Microbiol Lett; 2007 Aug; 273(2):187-95. PubMed ID: 17561947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers.
    Behrends C; Langer CA; Boteva R; Böttcher UM; Stemp MJ; Schaffar G; Rao BV; Giese A; Kretzschmar H; Siegers K; Hartl FU
    Mol Cell; 2006 Sep; 23(6):887-97. PubMed ID: 16973440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of Hsp70 with p49/STRAP, a serum response factor binding protein.
    Lin JL; Liu FH; Wang C
    Biochem Biophys Res Commun; 2009 Nov; 389(4):607-11. PubMed ID: 19751705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for sequestration of polyglutamine inclusions by Drosophila myeloid leukemia factor.
    Kim WY; Fayazi Z; Bao X; Higgins D; Kazemi-Esfarjani P
    Mol Cell Neurosci; 2005 Aug; 29(4):536-44. PubMed ID: 15936212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAT-Hsp40 inhibits oxidative stress-mediated cytotoxicity via the inhibition of Hsp70 ubiquitination.
    Kim SA; Chang S; Yoon JH; Ahn SG
    FEBS Lett; 2008 Mar; 582(5):734-40. PubMed ID: 18258197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsp70 and Hsp40 functionally interact with soluble mutant huntingtin oligomers in a classic ATP-dependent reaction cycle.
    Lotz GP; Legleiter J; Aron R; Mitchell EJ; Huang SY; Ng C; Glabe C; Thompson LM; Muchowski PJ
    J Biol Chem; 2010 Dec; 285(49):38183-93. PubMed ID: 20864533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of Hsc70 and Hsp70 in glial cytoplasmic inclusions in patients with multiple system atrophy.
    Kawamoto Y; Akiguchi I; Shirakashi Y; Honjo Y; Tomimoto H; Takahashi R; Budka H
    Brain Res; 2007 Mar; 1136(1):219-27. PubMed ID: 17240362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsp40 molecules that target to the ubiquitin-proteasome system decrease inclusion formation in models of polyglutamine disease.
    Howarth JL; Kelly S; Keasey MP; Glover CP; Lee YB; Mitrophanous K; Chapple JP; Gallo JM; Cheetham ME; Uney JB
    Mol Ther; 2007 Jun; 15(6):1100-5. PubMed ID: 17426712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.